1. Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends Fertil Steril 1991; 56:192.
2. Hacettepe University Institute of Population Studies (2004), 2003 Turkey Demographic and Health Survey, HUIPS, Ankara.
3. Speroff L, Glass NH, Kase RG. Clinical Gynecologic Endocrinology and Infertility. 7th edition.
2005:1215-74.
4. Feghali J, Bakar J, Mayenga JM, Se´gard L, Hamou J, Driguez P, Belaisch-Allart J. Systematic hysteroscopy prior to in vitro fertilization. Gynecol Obstet Fertil 2003; 31:127-131.
5. Filomenamila L, Oronzo C, Stefano B, Giuseppina L, Alfredo C, Giuseppe S, Raffaella D. Office hysteroscopy in an in vitro fertilization program, Gynecological Endocrinology 2008;24:8,465-469.
6. Yucebilgin MS, Aktan E, Bozkurt K, Kazandi M, Akercan F, Mgoyi L, Terek MC. Comparison of hydrosonography and diagnostic hysteroscopy in the evaluation of infertile patients. Clin Exp Obstet Gynecol 2004; 31:56-8.
7. Prevedourakis C, Loutradis D, Kalianidis C, Makris N, Aravantinos D. Hysterosalpingography and hysteroscopy in female infertility. Hum Reprod 1994; 9:2353-5.
8. Bozdağ G, Aksan G, Esinler I, Yaralı H. What is the role of office hysteroscopy in women with failed IVF-ICSI/ET cycles? Reprod Biomed Online 2008; 17:410-5.
9. Bettocchi S, Nappi L, Ceci O, Pontrelli G, Pinto L, Selvaggi L. Hysteroscopy and menopause: past and future. Curr Opin Obstet Gynecol 2005; 17:366-75.
10. Clark TJ. Outpatient hysteroscopy and ultrasonography in the management of endometrial disease.
Curr Opin Obstet Gynecol 2004; 16:305-11.
11. Rama Raju GA, Shashi K. Assessment of uterine cavity by hysteroscopy in assisted reproduction programme and its influence on pregnancy outcome Arch Gynecol Obstet 2006; 274:160-164.
12. Nicola D, Paola P, Francesca DS, Elena M, Lucıa DS, Elisa R, Francesco F, Claudio B, Augusto F. Pathologic findings in hysteroscopy before in vitro fertilization-embryo transfer (IVF-ICSI/ET-ET), Gynecological Endocrinology 2005; 21: 235-237.
13. Filomenamila L, Oronzo C, Stefano B, Giuseppina L, Alfredo C, Giuseppe S, Raffaella D. Office hysteroscopy in an in vitro fertilization program, Gynecological Endocrinology 24:8,465-469.
65
13. Marc AF, Speroff L. Clinical Gynecologic Endocrinology and İnfertility, Eighth Edition: Female Infertility 2011; 1137-1190.
14. Makar RS, Toth TL. The evaluation of infertility. Am J Clin Pathol 2002; 117:95-103.
15. Bernard J, Charles P, Jorna T. Spermatogenesisin vitro in mammals. In Assisted Reproductive Technology. Jonge CD, Barratt CLR, eds. Cambridge University Press: Cambridge, 2002;3-25.
16. Brannstorm M, Zackrisson U, Hagstrom HG. Preovulatuar changes of blood flow in different regions of the human follicle. Fertil Steril 1998; 69:435-42.
17. Vermesh M, Kletzky OA, Dajavan V, Israel R. Monitoring techniques to predict and detect ovulation. Fertil Steril 1987; 47:259-64.
18. Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J 1984; 288: 7-9.
19. Duggan MA, Brashert P, Ostor A, Scurry J, Billson V, Kneafsey P. The accuracy and interobserver reproducibility of endometrial dating. Pathology 2001; 33: 292-7.
20. Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 1997; 337:217-22.
21. Dubuisson JB, Bouquet de Joliniere J, Aubriot FX, Darai E, Foulot H, Mandelbrot L. Terminal tuboplasties by laparoscopy: 65 consecutive cases. Fertil Steril 1990; 54:401-3.
22. Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility? The importance of hydrosalpinx fluid. Hum Reprod 2002; 17:1141-5.
23. Hinckley MD, Milki AA. 1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings. JSLS 2004; 8(2):103-7.
24. Lopata A, Bentin-Ley U, Enders A. Pinopodes and implantation. Rev Endocr Metab Disord 2002; 3 77-86.
25. Sharkey AM, Smith SK. The endometrium as a cause of implantation failure. Best Pract Res Clin Obstet Gynaecol 2003; 17 289-307.
26. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2012.
66
27. Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury of the endometrium doubles the incidence of succesful pregnancies in patients undergoing in-vitro fertilization, Fertil Steril 2003; 79:1317-1322.
28. Seibel MM. Emotional aspects of infertility. Fertil Steril 1982; 37:137-45.
29. Pinheiro RC, Lambert J, Benard F, Mauffette F, Miron P. Effectiveness of in vitro fertilization with intracytoplasmic sperm injection for severe male infertility. CMAJ 1999; 30:161-172.
30. Vicdan K, Işık AZ. İn vitro fertilizasyon ve mikromanipülasyon uygulamalarında laboratuvar.
Çağdaş Medikal Kitapevi, 1999.
31. Gardner DK, Weissman A, Howles CM, Shoham Z. Textbook of assisted reproductive techniques laboratory and clinical perspectives. London and New York, A Martin Dunitz Book, 2004.
32. Trounson A, Gardner DK. Handbook of in vitro fertilization. CRC Press, Victoria, Australia, 1993.
33. Berek JS, Adashi EY, Hillard PA. Novak Jinelokoji. 1996, 1998 Williams& Wilkins, Baltimore-Nobel, İstanbul.
34. Kistner RW. Ovualtion: clinical aspects. In Balin H. And Glasser S. (eds) Reproductive Biology.
Excerpta Medica, Amsterdam, 1972; 477. 46.
35. Kistner RW. Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction. Fertil Steril 1976; 27:72-82.
36. March CM, Tredway DR, Mishell DR. Effect of pretreatment with clomiphene citrate upon human menopausal gonadotropin therapy for anovulation. Fertil Steril 1975; 26:191-192.
37. Taymor ML, Berger MJ, Nudemberg F. The combined use of clomiphene citrate and human menopausal gonadtropin in ovulation induction. In Hasegawa T, Hayashi M, Ebling FJG, Henderson IW. (eds) Fertil Steril, Proceedings of the VII World Congress, Tokyo. Excerpta Medica Int Congress Series 278, Amsterdam, 1973:658.
38. Lu PY, Lee SH, Chen ALJ, Erickson LD, Atkinson EJ, Ory SJ. Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadtropins in the treatment of fertility. Fertil Steril 1996; 65:583-7.
39. Smith B, Porter R, Ahuja K, Craft I. Ultrasonic assessment of endometrial changes in stimulated cycles in an in vitro fertilization and embryo transfer program. J In Vitro Fert Embryo Transf 1984;
1:233-8.
40. Brzechffa PR, Daneshmand S, Buyalos RP. Sequential clomiphene citrate and human menopausal gonadotropin with intrauterine insemination: the effect of patient age on clinical outcome. Hum Reprod 1998; 13.2110-14.
67
41. Shoham Z, Di Carlo C, Patel A, Conwoy GS, Jacobs HS. Is it possible to run a successful ovulation induction program based solely on ultrasound monitoring? The importance of endometrial measurements. Fertil Steril 1991; 56:836-41.
42. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH, Matulich EM. Relationship of follicle number, serum estradiol and other factors to birth rate and multiparity in human menopausal gonadotropin-induced intrautureine insemination cycles. Fertil Steril 1991; 56:89-92.
43. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997; 3:359-365.
44. Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY, Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Hum Reprod 1997; 12:449-453.
45. Gysler M, March CM, Mishell DR Jr, Bailey EJ. A decade’s experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982; 37:161- 167.
46. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998; 83:2361-2365.
47. Dickey RP, Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 1996; 2:483-506.
48. Trott EA, Plouffe L Jr, Hansen K, Hines R, Brann DW, Mahesh VB. Ovulation induction in clomipheneresistant anovulatory women with normal dehydroepiandrosterone sulfate levels:
beneficial effects of the addition of dexamethasone during the follicular phase. Fertil Steril 1996;
66:484-486.
49. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305-309.
50. Meldrum D. GnRH agonists as adjuncts for in vitro fertilization, Obstet Gynecol 1989; 44:314.
51. Janssens RM, Lambalk CB, Vermeiden JP, Schats R, Bernards JM, RekersMombarg LT, Schoemaker J. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF-ICSI/ET: a prospective randomized, double blind, placebo-controlled study, Hum Reprod 2000;
15: 2333.
52. Hughes EG, Federkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: meta-analysis of randomised controlled trial, Fertil Steril 1992; 58:888.
53. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles, Cochrane Database Syst Rev 2000; 12-99.
68
54. Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Huynh D, Kempton W. Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression, Fertil Steril 1988;
50:400.
55. Urbancsek J, Witthaus E. Midluteal buserelin is superior to early follicular phase 49 buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization, Fertil Steril 1996; 65:966.
56. Ron-El R, Hermann A, Golan A, Nachum H, Soffer Y, Caspi E. Gonadotropins and combined gonadotropin-releasing hormone agonist-gonadotropins protocols in a randomized prospective study, Fertil Steril 1991; 55:574.
57. Fitzgerald PA. Hypothlamic and pituitary hormones. In Katzung BG (ed), Basic and clinical pharmacology. California: Mcgraw-Hill, 8th ed, 2001:625-643.
58. Reissmann T, Schally AV, Bouchard P. The LHRH antagonist Cetrorelix: a review. Human Reproduction Update 2000; 6:322-331.
59. Brick NS. Teresa Wiesak Shore Institute for Reproductive Medicine USA. Role of LH in controlled ovarian stimulation. Reproductive Biology 2002; 2:215-227.
60. Griesinger G, Felferbaum R, Diedrich K. GnRH antagonists in ovarian hyperstimulation: a treatment regimen of clinician’s second choice? Data from the German national IVF registry. Human Reproduction 2005; 20:2373-2375.
61. Ron-El R, Lazrel A, Schachter M. Induction of ovulation after GnRH antagonists. Human Reproduction Update 2000; 6:318-321.
62. Olivennes F, Alvarez J, Bouchard P. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: adose finding study of 3 versus 2 mg. Human Reproduction 1998;
13:2411-2414.
63. Olivennes F, Belcisch-Allart J, Emperaire JC. Prospective, randomised, controlled study of in-vitro fertilization-embryo transfer with a single dose of a luteinizing hormone releasing hormone (LH-RH) antagonist (Cetrorelix) or a depot formula of an LH-RH agonist (Triptorelin). Fertility and Sterility 2000; 73:314-320.
64. Schiano L, Colombo V, Savası C, Bulletti C, Albani E, Ferrazzi E. Implantation Failure in Assisted Reproduction Technology and a Critical Approach to Treatment Ann N Y Acad Sci 2004;
1034:184-99.
65. Karimzadeh MA, Rozbahani A, Tabibnejad N. Endometrial local injury improves the pregnancy rate among recurrent implantation failure patients undergoing in vitro fertilisation/intra cytoplasmic sperm injection: a randomised clinical trial, Aust N Z J Obstet Gynaecol 2009; 49:677-680.
69
66. Narvekar SA, Gupta N, Shetty N, Kottur A, Srinivas M, Rao K. Does local endometrial injury in the nontransfer cycle improve the IVF-ICSI/ET, outcome in the subsequent cycle in patients with previous unsuccessful IVF-ICSI/ET? A randomized controlled pilot study. J Hum Reprod Sci 2010;
3:15-9.
67. Shohayeb A, El-Khayat W. Does a single endometrial biopsy regimen (S-EBR) improve ICSI outcome in patients with repeated implantation failure? A randomised controlled trial. Eur J Obstet Gynecol Reprod Biol 2012; 164:176-179.
68. Potdar N, Gelbaya T, Nardo LG. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod Biomed Online 2012; 25:561-571.
69. Bahadur A, Malhotra N, Singh N, Gurunath S, Mittal S. Comparative study on the role of diagnostic hysteroscopy in evaluation of the uterine cavity prior to in vitro fertilization in a developing country. Arch Gynecol Obstet 2013; 288:1137-1143.
70. Karayalcin R, Ozyer S, Ozcan S, Uzunlar O, Gurlek B, Moraloglu O, Batioglu S. Office hysteroscopy improves pregnancy rates following IVF-ICSI/ET. Rep Bio Med Online 2012; 25: 261-266.
71. Demirol A, Gurgan T. Effect of treatment of intrauterine pathologies with office hysteroscopy in patients with recurrent IVF-ICSI/ET failure. Reprod Biomed Online. 2004; 8:590-4.
72. Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 2007; 25 445-453.
73. Psychoyos A. Uterine receptivity for nidation. Ann N Y Acad Sci 1986; 476 36-42.
74. Ma WG, Song H, Das SK, Paria BC, Dey SK. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci USA 2003;
100:2963-2968.
75. Simon C, Martin JC, Pellicer A. Paracrine regulators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:815-826.
76 Simon C, Valbuena D. Embryonic implantation. Ann Endocrinol (Paris) 1999; 60:134-136.
77. Kengni JH, St-Louis I, Parent S, Leblanc V, Shooner C, Asselin E. Regulation of prostaglandin D synthase and prostacyclin synthase in the endometrium of cyclic, pregnant, and pseudopregnant rats and their regulation by sex steroids. J Endocrinol 2007; 195:301-311.
78. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003; 327:368.
70
79. Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: Network of hormones, cytokines, and growth factors. J Endocrinol 2011: 3.
80. Karayalcin R, Ozcan S, Moraloglu O, Ozyer S, Mollamahmutoglu L, Batıoglu S. Results of 2500 office-based diagnostic hysteroscopies before IVF-ICSI/ET. Reprod Biomed Online. 2010; 20:689-93.
81. Valle RF. Therapeutic hysteroscopy in infertility. Int J Fertil 1984; 29:143-48.
82 Blank B. Endometrial polyps. In: Blanc B, Marty R, de MontgolWer R (eds) Officce and operative hysteroscopy, Springer, Heidelberg, 2002:173.
83. Rackow BW, Jorgensen E, Taylor HS. Endometrial polyps affect uterine receptivity. Fertil Steril.
2011; 24.
84. Richlin SS, Ramachandran S, Shanti A, Murphy AA, Parthasarathy S. Glycodelin levels in uterine flushings and in plasma of patients with leiomyomas and polyps: implications for implantation.
Human Reproduction 2002; 17:2742-2747.
85. Stamatellos I, Apostolides A, Stamatopoulos P, Bontis J. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps. Arch Gynecol Obstet 2008; 277:395-9.
86. Keltz M, Varasteh N, Levin B, Neuwirth R. Pregnancy rates following hysteroscopic polypectomy, myomectomy, and a normal cavity in infertile patients. Prim Care Update Ob Gyns 1998; 5:168.
87. Practice Committee of the American Society for Reproductive. Medicine Myomas and reproductive function. Fertil Steril 2004; 82:111-116.
88. Wamsteker K, EmanuelMH, Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extention. Obstet Gynecol 1993; 82:736-40.
89. Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 2010; 93:2027-34.
90. Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet 2005; 273:50-4.
91. Acien P. Incidence of Mullerian defects in fertile and infertile women. Hum Reprod 1997; 12:1372-1376.
92. Pellicer A. Shall we operate on Mullerian defects? An introduction to the debate. Hum Reprod 1997;
12:1371-1372.
71
93. Burchell RC, Creed F, Rasoulpour M, Whitcomb M.Vascular anatomy of the human uterus and pregnancy wastage. Br J Obstet Gynaecol 1978; 85:698-706.
94. Speroff L, Glass RH, Kase NG. Female infertility. In: Speroff L, Fritz MA (eds) Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams and Wilkins, Philadelphia PA, 2005:1013-1067.
95. Tomaževič T, Ban- Frangež H, Virant-Klun I, Verdenik I, Požlep B, Vrtačnik-Bokal E. Septate, subseptate and arcuate uterus decrease pregnancy and live birth rates in IVF-ICSI/ET/ICSI, Reprod Biomed Online 2010; 21:700-5.
96. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results, Hum Reprod Update 2001; 7:161-74.
97. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril. 2000; 73:1-14.
98. Asherman JG. Amenorrhoea traumatica (alretica). J Obstet Gynaecol Br Emp 1948; 55:22-30.
99. Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp 1950; 57:892-896.
100. Kodaman PH, Arici A. Intra-uterine adhesions and fertility outcome: how to optimize success?, Curr Opin Obstet Gynecol 2007; 19:207-14.
101. Berman JM. Intrauterine adhesions. Semin Reprod Med 2008; 26:349-55.
102. Sharma JB, Roy KK, Pushparaj M, Kumar S. Hysteroscopic findings in women with primary and secondary infertility due to genital tuberculosis. Int J Gynaecol Obstet. 2009; 104:49-52.
103. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome–one centurylater. Fertil Steril 2008; 89:759-79.
104. Myers EM, Hurst BS. Comprehensive management of severe Asherman syndromeand amenorrhea.
Fertil Steril 2012; 97:160-4.
105. Malhotra N, Bahadur A, Kalaivani M, Mittal S. Changes in endometrialreceptivity in women with Asherman’s syndrome undergoing hysteroscopicadhesiolysis. Arch Gynecol Obstet 2012;
286:525-30.
106. Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman’s syndrome. Arch Gynecol Obstet 2010; 281:355-61.
72
107. Pabuçcu R, Atay V, Orhon E, Urman B, Ergün A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility, Fertil Steril.
1997; 68:1141-3.
108. Rafael FV. Manual of Clinical Hysteroscopy, Second Edition, Hardcover, 2005:1-7.
109. Font-Sastre V, Carabias J, Bonilla-Musoles F, Pellicer A. Office hysteroscopy with small caliber instruments. Acta Eur Fertil 1986; 17:427-429.
110. Bradley L, Falcone, T. Hysteroscopy: office evaluation and management of the uterine cavity, Royal College of Obstetricians and Gynaecologists 2008; 35.
111. Shapiro BS. Instrumentation in hysteroscopy. Obstet Gynecol Clin North Am 1988; 15:13-21.
112. American Collage of Obstetricians and Gynecologists. Hysteroscopy. ACOG Technical Bulletin Number 191- April 1994. Int J Gynaecol Obstet 1994; 45: 175-180.
113. Günalp S, Yüce K. Temel Kadın Hastalıkları ve Doğum Bilgisi, Üçüncü Baskı, 2014; 47:516-528.
114. Marlow JL. Media and delivery systems. Obstet Gynecol Clin North Am 1995; 22:409-422.
115. De Placido G, Clarizia R, Cadente C, Castaldo G, Romano C, Mollo A, Alviggi C, Conforti S.
Compliance and diagnostic efficacy of mini-hysteroscopy versus traditional hysteroscopy in infertility investigation, Eur J Obstet Gynecol Reprod Biol 2007; 135:83-7.
116. Pluchino N, Ninni F, Angioni S, Artini P, Araujo VG, Massimetti G, Genazzani AR, Cela V.
Office vaginoscopic hysteroscopy in infertile women: effects of gynecologist experience, instrument size, and distention medium on patient discomfort. J Minim Invasive Gynecol 2010; 17:344-50.
117 Cooper JM, Brady RM. Late complications of operative hysteroscopy. Obstet Gynecol Clin North Am 1999; 26:217-236.
118. Propst AM, Liberman RF, Harlow BL, Ginsburg ES. Complications of hysteroscopic surgery:
predicting patients at risk. Obstet Gynecol 2000; 96:517-520.
119. Crescini C, Artuso A, Repetti F. Hysteroscopic diagnosis in patients with abnormal uterine hemorrhage and previous endometrial curettage. Minerva Gynecol 1992; 44:233-235.
120. Brill A. Energy systems for operative hysteroscopy. Obstet Gynecol Clin North Am 2000; 27:317-326.
121. Luciano AA. Power sources. Obstet Gynecol Clin North Am 1995; 22:423-443.
73
122. Gimpelson RJ. Office hysteroscopy. Clin Obstet Gynecol 1992; 35:270-281.
123. Golan A, Ron-El R, Herman A. Diagnostic hysteroscopy its value in an in-vitro fertilization/embryo transfer unit. Hum Reprod 1992; 7:1433-1434.
124. Doldi N, Persico P, Sebastiano DJ, Marsiglio E, De Santis L, Rebellotti E, Fusi F, Brigante C, Ferrari A. Pathologic findings in hysteroscopy before in vitro fertilization-embryo transfer (IVF-ICSI/ET-ET). Gynecol Endocrinol 2005; 21:235-237.
125. Varasteh NN, Neuwirth RS, Levin B, Keltz MD. Pregnancy rates after hysteroscopic polypectomy and myomektomy in infertile women. Obstet Gynecol 1999; 94:168-171.
126. Batioglu S, Kaymak O. Does hysteroscopic polypectomy without cycle cancellation affect IVF-ICSI/ET? Reprod Biomed Online 2005; 10:767-769.
127. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002; 17:1424-1430.
128. Pritts EA. Fibroids and fertility: a systematic review of the evidence. Obstet Gynecol Surv 2001;
56:483-491.
129. Friedler S, Margalioth EJ, Kafka I, Yaffe H. Incidence of post- abortion intrauterin adhesions evaluated by hysteroscopy a prospective study. Hum Reprod 1993; 8:442-444.
130. Broome JD, Vancaille TG. Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome. Obstet Gynecol 1999; 71:219-222.
131. Taylor E, Gomel V. The uterus and fertility. Fertil Steril 2008; 89:1-16.
132. Mollo A, De Franciscis P, Colacurci N, Cobellis L, Perino A, Venezia R. Hysteroscopic resection of the septum improves the pregnancy rate of women with unexplained infertility: a prospective controlled trial. Fertil Steril 2009; 91:2628-2631.
133. El-Nashar IH, Nasr A. The role of hysteroscopy before intracytoplasmic sperm injection (ICSI): a randomized controlled trial. Ferti Steril 2011; 96:15-282.
134. Trniniç-Pjeviç A, Kopitoviç V, Pop-Trajkoviç S, Bjelica A, Bujas I, Tabs D, Iliç D, Stajiç D.
Effect of hysteroscopic examination on the outcome of in vitro fertilization. Vojnosanit Pregl 2011;
68:476-480.
135. Yeung YWT, Chai J, Hang Wun Li R, Lee VCY, Ho PC, Yu Ng EH. The effect of endometrial injury on ongoing pregnancy rate in unselected subfertile omen undergoing in vitro fertilization: a randomized controlled trial. Hum Reprod 2014; 11:2474-2481.
74
136. Margalioth EJ, Ben-Chetrit A, Gal M. Investigation and treatment of repeated implantation failure following IVF-ICSI/ET-ET. Hum Reprod 2006; 21:3036-3043.
137. Zhou L, Li R, Wang R, Huang HX, Zhong K. Local injury to the endometriumin controlled ovarian hyperstimulation cycles improves implantation rates. Fertil Steril 2008; 89:1166-76.
138. Raziel A, Schachter M, Strassburger D, Berno O, Ron-El R, Friedler S. Favorable influence of local injury to the endometrium in intracytoplasmic intracytoplasmicsperm injection patients with high-order implantation failure. Fertil Steril 2007; 87:198-20.
139. Narvekar SA, Gupta N, Shetty N, Kottur A, Srinivas M, Rao KA. Does local endometrial injury in the nontransfer cycle improve the IVF-ICSI/ET-ET outcome in the subsequent cycle in patients with previous unsuccessful IVF-ICSI/ET? A randomized controlled pilot study. J Hum Reprod Sci 2010; 3:15-9.
140. Rama R, Kumari S. Assessment of uterine cavity by hysteroscopy in assisted reproduction programme and its influence on pregnancy outcome Arch Gynecol Obstet 2006; 274:160-164.
141. Kasius JC, Broekmans FJM, Veersema S, Eijkemans MJC, Van Sandbrink EJP, Devroey P, Fauser BCJM, Fatemi HM. Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization, Hum Reprod 2011; 26:801-807.
142. Pundir J, Pundir V, Omanwa K, Khalaf Y, El-Toukhy T. Hysteroscopy prior to the first IVF-ICSI/ET cycle: A systematic review and meta- analysis. Rep Bio Med Online 2014; 28:151-161.
143. Shapiro BS. Instrumentation in hysteroscopy. Obstet Gynecol Clin North Am 1988; 15:13-21.
144. Ragni G, Diaferia D, Vegetti W, Colombo M, Arnoldi M, Crosignani PG. Effectiveness of sonohysterography in infertile patient work-up: a comparison with transvaginal ultrasonography and hysteroscopy, Gynecol Obstet Invest 2005; 59:184-8.
145. Lorusso F, Ceci O, Bettocchi S, Lamanna G, Costantino A. Office hysteroscopy in an in vitro fertilization program, Gynecol Endocrinol 2008; 24:465-9.
146. Munné S. Preimplantation genetic diagnosis and human implantation-a review. Placenta 2003;
24:70-76.
75